Ernexa Therapeutics Inc. logo

ERNAErnexa Therapeutics Inc.

ERNA Stock Price, Valuation & Chart | Ernexa Therapeutics Inc.

Compare

ERNA Historical price chart

ERNA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization1.43M
PE Ratio-0.57
EPS-7.96
Trading Volume23.23K
Today's High/Low4.8/4.45
Dividend Yield0.00
52 Week High/Low71.5/3.18
Shares Outstanding314.12K
ERNA Financial Statement
ERNA Analyst ratings
ERNA Analysis & performance metrics

ERNA Company profile

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune…

ERNA Management team

Management
Dorothy J. Clarke
General Counsel
Sanjeev LutherCEO
Chief Executive Officer, President & Director
Robert Hamilton Pierce M.D.
Chief Scientific Officer
Sandra M. Gurrola
Principal Financial & Accounting Officer and Senior Vice President of Finance
Total 4 executives

ERNA Frequently asked questions

What is Ernexa Therapeutics Inc. (ERNA) Stock Price?

Current stock price of Ernexa Therapeutics Inc. (ERNA) stock is $4.540. The stock price is +4.37% higher in the session. The intraday range can be seen from this page. Volume of Ernexa Therapeutics Inc. (ERNA) stock is 23.23K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Ernexa Therapeutics Inc. (ERNA) stock price going up or down today?

The stock price of Ernexa Therapeutics Inc. (ERNA) can change with earnings, company news, and overall market sentiment. Ernexa Therapeutics Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Ernexa Therapeutics Inc. stock expensive at its current price?

Whether Ernexa Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ERNA on this page is -0.57. EPS on this page is -7.96. Compare those figures with peers and growth expectations before deciding if the current Ernexa Therapeutics Inc. price is justified.

How has the stock price of Ernexa Therapeutics Inc. (ERNA) performed historically?

Historical performance for Ernexa Therapeutics Inc. (ERNA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ERNA reacted to past earnings and market events.

Should I buy Ernexa Therapeutics Inc. (ERNA) stock, at this price?

Buying Ernexa Therapeutics Inc. (ERNA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.